propofol + alfentanil + lidocaine

This is a combination of three pharmaceutical agents—propofol, alfentanil, and lidocaine—used together primarily for induction and maintenance of anesthesia or sedation during surgical or diagnostic procedures. - **Propofol** is an intravenous general anesthetic that acts as a positive allosteric modulator at the gamma-aminobutyric acid type A (GABA-A) receptor, enhancing inhibitory neurotransmission in the central nervous system to produce hypnosis and sedation[6][7][8]. - **Alfentanil** is a potent, short-acting synthetic opioid analgesic that acts as an agonist at the mu-opioid receptor, providing rapid-onset analgesia and supplementing anesthesia[1][2][3]. - **Lidocaine** is an amide-type local anesthetic that blocks voltage-gated sodium channels in neuronal membranes, inhibiting nerve impulse conduction to provide local anesthesia and reduce pain associated with propofol injection[5]. The combination leverages synergistic effects for improved intubating conditions, enhanced sedation/analgesia, reduced pain on injection (from propofol), and potentially lower doses of each agent compared to monotherapy. This mixture has been studied for use in both adult and pediatric populations undergoing various procedures requiring general anesthesia or deep sedation[1][2][3][5].